Hartree Partners, LP
- SEC CIK
- 0001597857
- Latest filing
- Aug 12, 2026
SLXNW holding history
Silexion Therapeutics Corp in every 13F filed by Hartree Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SLXNW overviewAll 13F holders of SLXNWFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −182,355−100.0% | Sold out | Holders |
| Q2 2025 | 182,355 | $7.29K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 182,355 | $14.6K | <0.1% | −5,145−2.7% | Reduced | Holders |
| Q4 2024 | 187,500 | $5.63K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 187,500 | $5.63K | <0.1% | +187,500 | New | Holders |